Literature DB >> 31397387

C-reactive protein as a prognostic marker of Plasmodiumfalciparum malaria severity.

Nitin Bhardwaj1, Md Zohaib Ahmed1, Supriya Sharma2, A Nayak2, Anupkumar R Anvikar2, Veena Pande3.   

Abstract

BACKGROUND &
OBJECTIVES: Plasmodiumfalciparum malaria causes wide variety of clinical symptoms ranging from a mild febrile illness to life-threatening complications. For prevention of the severity and early diagnosis, evaluation of potential biomarkers is much needed. C-reactive protein (CRP) is an acute phase protein and well-recognized marker of inflammation in the body. It is synthesized by liver in response to pro-inflammatory responses and has correlation with complications associated with malaria. The study was aimed to assess, if it could serve as a predictive marker for malaria disease severity.
METHODS: In the present study, 74 P. falciparum patients and 22 healthy controls were enrolled. Turbidimetric immunoassay was used to measure the CRP in serum samples of all the study participants. Mann-Whitney U-test for continuous data and chi-square test for categorical data were used to compare all malaria cases vs. healthy control group and uncomplicated vs. severe malaria groups. Using receiver operating characteristic (ROC) analysis, best threshold value was determined for CRP in severe malaria patients.
RESULTS: CRP level was significantly elevated in all malaria case groups (1.6 mg/dl IQ 1-2.6) as compared to healthy controls (0.10 mg/dl IQ 0.1-0.20), with p-value <0.0001. Further, CRP level was significantly higher in the severe malaria group (2 mg/dl IQ 1.8-3.9) as compared to the uncomplicated malaria group (1.4 mg/dl IQ 1-2.47) and healthy control group (0.10 mg/dl IQ 0.10-0.20), with p-value <0.05. INTERPRETATION &
CONCLUSION: The present study findings suggest that CRP level can be used to differentiate severe malaria from uncomplicated malaria. Elevated CRP level could be helpful in early prediction of the disease severity in patients infected with P. falciparum and may play an important role in diagnosis of falciparum malaria where improper initial test and clinical manifestations like fever may be absent even with a high load of parasite.

Entities:  

Keywords:  Biomarker; C-reactive protein; Plasmodium falciparum; malaria; severe malaria; uncomplicated malaria

Mesh:

Substances:

Year:  2019        PMID: 31397387     DOI: 10.4103/0972-9062.263727

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  6 in total

1.  Factors associated with prolonged hospital stay of imported malaria cases in Chengdu, China: a retrospective study.

Authors:  Liang Huang; Hong Jin; Hong Zhang; Yang Liu; Xinxing Shi; Xintong Kang; Yilan Zeng; Lin Wang
Journal:  BMC Infect Dis       Date:  2022-05-26       Impact factor: 3.667

2.  Clinical trials to assess adjuvant therapeutics for severe malaria.

Authors:  Rosauro Varo; Clara Erice; Sydney Johnson; Quique Bassat; Kevin C Kain
Journal:  Malar J       Date:  2020-07-24       Impact factor: 2.979

3.  C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors in vitro.

Authors:  A Robin Temming; Matthias Tammes Buirs; Arthur E H Bentlage; Louise W Treffers; Hannah Feringa; Steven W de Taeye; Taco W Kuijpers; Sietse Q Nagelkerke; Giso Brasser; Juk Yee Mok; Wim J E van Esch; Timo K van den Berg; Theo Rispens; C Ellen van der Schoot; Gestur Vidarsson
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

4.  C-reactive protein as an early biomarker for malaria infection and monitoring of malaria severity: a meta-analysis.

Authors:  Polrat Wilairatana; Praphassorn Mahannop; Thanita Tussato; I-Mee Hayeedoloh; Rachasak Boonhok; Wiyada Kwanhian Klangbud; Wanida Mala; Kwuntida Uthaisar Kotepui; Manas Kotepui
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

Review 5.  The spectrum of clinical biomarkers in severe malaria and new avenues for exploration.

Authors:  Loick Pradel Kojom Foko; Geetika Narang; Suman Tamang; Joseph Hawadak; Jahnvi Jakhan; Amit Sharma; Vineeta Singh
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

6.  Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis.

Authors:  Aongart Mahittikorn; Kwuntida Uthaisar Kotepui; Wanida Mala; Polrat Wilairatana; Manas Kotepui
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.